Instil Bio Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Instil Bio (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, today reported its second quarter 2022…

HCW Biologics (NASDAQ: HCWB) Reports Second Quarter 2022 Financial Results And Recent Business Highlights

HCW Biologics (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between chronic, low-grade inflammation and age-related diseases, today reported…

Access Healthcare Named In The Top 100 Healthcare Technology Companies Of 2022

Access Healthcare, leading technology and business process service provider, has been named in the Top 100 Healthcare Technology Companies of 2022 by The Healthcare Technology Report. With the inclusion, Access joins…

Boston Hemp Inc. Partners With Herb.Co To Bring National Attention To Their Brand

It is announced today that Boston Hemp Inc., one of the nation’s top retailers of premium hemp products has partnered with Herb.co to promote their brand on a national level. Herb is…